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Posttraumatic Stress Disorder in the Wake of Heart Disease: Prevalence, Risk
Factors, and Future Research Directions
HELLE SPINDLER, MSC, AND SUSANNE S. PEDERSEN, PHD
Background: There is increasing recognition that patients after a cardiac event may be at risk of posttraumatic stress disorder
(PTSD). The present article reviews studies looking at PTSD as a sequel of heart disease with a focus on prevalence, risk factors,
and future research directions. Methods: We conducted a search on PsychInfo and MEDLINE from 1980 to the present. Studies
were included in the review if they looked at PTSD after a cardiac event, reported on the number of cases with PTSD, and had been
published in English. Results: We identified 25 studies that fulfilled the inclusion criteria, of which 7 reported on the follow-up
of previously published studies. The prevalence of PTSD after heart disease varied from 0% to 38% across studies. PTSD has been
most rigorously researched after myocardial infarction with the best-powered studies finding a prevalence rate of 15%. Studies
including control groups showed that cardiac patients were at risk of developing PTSD. Risk factors included sociodemographic
and psychological characteristics and aspects related to the cardiac event. Conclusion: Despite substantial heterogeneity in the
methodology of studies and differences in prevalence across studies, this review indicates that subgroups of patients are at risk of
PTSD after a cardiac event. Future studies investigating PTSD as a sequel of heart disease should be more systematic, use a
prospective study design with multiple assessments, and include sufficiently large samples. PTSD should not be ignored as a sequel
of heart disease, given preliminary evidence that PTSD may be associated with nonadherence with medication and an increased risk
of clinical adverse events. Key words: coronary artery disease, posttraumatic stress disorder, prevalence, risk, review.
CAD  coronary artery disease; HT  heart transplantation;
PTSD  posttraumatic stress disorder; MI  myocardial infarc-
tion; SCA  sudden cardiac arrest; CHF  congestive heart failure;
CS  cardiac surgery; PCI  percutaneous coronary intervention;
CABG  coronary artery bypass surgery; DSM  Diagnostic and
Statistical Manual.
INTRODUCTION
Coronary artery disease (CAD) is the most prominent causeof death in the Western world, but CAD may also lead to
significant morbidity in patients who survive an initial cardiac
event. Due to improvement in treatment options, the number
of patients who survive a myocardial infarction (MI) has
increased substantially; paired with an aging population, the
burden of CAD is expected to increase significantly in the
future, posing a major challenge to secondary prevention (1).
However, despite advances in diagnosis and treatment of
CAD, subgroups of patients may not benefit optimally from
treatment, placing them at a higher risk for mortality and
impaired health status (2–5). The identification of factors that
influence the pathogenesis of CAD is therefore important for
secondary prevention.
Posttraumatic stress disorder (PTSD) is one factor that has
been identified as influencing the pathogenesis and progres-
sion of CAD (6,7). PTSD also composes a possible conse-
quence of CAD (8–11). However, there is some debate
whether PTSD should be considered an illness in its own right
or whether it is a “fashionable” disorder that has appeared “out
of sociopolitical ideas” (12,13).
A diagnosis of PTSD was first introduced in the Diagnostic
and Statistical Manual (DSM) in 1980. In the DSM Third
Edition, the stressor criterion was defined as “a recognizable
stressor that would evoke significant symptoms of distress in
almost anyone” (14). In the DSM Third Edition Revised, it was
changed to “an event that is outside the range of usual human
experience and that would be markedly distressing to almost
anyone” (15). In both cases, focus was on the nature of the
event, and cardiac events did not qualify as potential stressors,
as they were not “outside the range of usual human experi-
ence.” In the DSM Fourth Edition (16), medical illness was
added explicitly as a qualifying event for PTSD, and the focus
was widened to include the subjective perception of the event.
This change in the diagnostic criteria for PTSD has made
cardiac events more likely to fulfill the stressor criterion,
which in turn may lead to an increase in the number of PTSD
cases identified in studies of cardiac patients. In an empirical
investigation of changes to the stressor criterion in DSM-IV,
Breslau and Kessler (17) showed that 38% of PTSD cases
were due to the addition of new qualifying events. However,
the change in the stressor criterion does not imply that medical
illness did not previously lead to PTSD symptoms in medical
patients. It rather shows that the diagnostic system had not
recognized that medical illness, including CAD, may be a
sufficient stressor leading to PTSD.
PTSD is also a common comorbid disorder with depres-
sion. The impact of depression on prognosis in patients with
established CAD has been studied extensively with depression
being associated with a 2-fold increased risk of mortality
(18,19). However, does the comorbidity between the 2 disor-
ders and the considerable amount of literature on depression
make it superfluous to study PTSD in its own right in cardiac
patients? Pathophysiological studies have associated both de-
pression and PTSD with increased secretion of corticotropin
releasing factor; however, contrary to the pathophysiology in
depression, this increased secretion is associated with hypo-
cortisolemia in PTSD, indicating that the pathophysiology of
the 2 disorders may be distinct (20). Another part of the
answer to this question may be found in the treatment litera-
ture, as treating depression does not necessarily lead to
improvement in PTSD symptoms, because conventional treat-
ment of depression is not aimed at the core symptoms of
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PTSD. Moreover, risk factors may often act in synergy, af-
fecting cardiac prognosis adversely (21). Hence, ignoring
PTSD and only treating depression may have severe conse-
quences for cardiac patients (21). For example, a recent study
did not show any adverse effects of depression on clinical
outcome and adherence with medication, but this was the case
for PTSD (22).
The Current Review
Several recent reviews have looked at the relationship
between medical illness and subsequent PTSD (8–10,23).
However, these reviews are either very broad in their scope,
incorporating such diverse areas as cardiac and vascular dis-
eases, obstetrics and gynecology, intensive care unit treat-
ment, cancer, and HIV (10), or narrow by focusing on one
specific cardiac event, such as MI (8). This review seeks to
expand on existing reviews by providing an up-to-date over-
view of the literature of studies on PTSD after cardiovascular
disease with a focus on prevalence rates, risk factors, and
future research directions.
We decided not only to focus on prevalence rates but also
on risk factors, given that knowledge of risk factors is impor-
tant in order to identify patients who may be at risk of PTSD
with a chronic course. In addition, we included not only acute
but also chronic cardiac events, such as congestive heart
failure (CHF). Acute events may be more likely to lead to
PTSD, but investigation of whether chronic conditions also
comprise a risk factor for PTSD is important for secondary
prevention. The risk to CHF patients of developing PTSD
seems particularly important because CHF is an “emerging
epidemic” due to an ageing population and the increase in the
number of patients who survive an initial infarction (1). More-
over, CHF is the end stage of most heart diseases, and if an
acute event, such as MI, can lead to PTSD, it seems likely that
CHF may also be a risk factor. In addition, PTSD has been
associated with an increased risk of nonadherence with med-
ication (22), and nonadherence in heart failure is a risk factor
for clinical adverse events (24).
METHODS
Identification of Studies for the Review
A literature search was conducted in the PsychInfo and MEDLINE
databases (1980 to present) using the search terms posttraumatic stress
disorder, cardiovascular disorders, cardiovascular diseases, myocardial in-
farction, AMI, CHD, CAD, CABG, bypass, PTCA, percutaneous transluminal
coronary angioplasty, angina pectoris, PCI, percutaneous coronary interven-
tion, cardiac surgery, ICD, implantable cardioverter defibrillator, heart fail-
ure, and heart transplantation. We also searched the reference lists of the
identified studies by hand. However, this did not lead to the addition of further
studies. No other hand searches were carried out. The first author carried out
the computer search and the hand search. Criteria for inclusion in the review
were as follows: (1) empirical study reporting on patients having had an MI,
sudden cardiac arrest (SCA), cardiac surgery (CS), heart transplantation (HT),
or CHF; (2) PTSD cases of the patients evaluated and reported as number of
positive cases or as a prevalence rate; (3) study published in English. Due to
time constraints, we did not contact authors, just as we did not use publica-
tions in languages other than English.
The search resulted in 109 hits in PsychInfo and 304 hits in MEDLINE.
Examining all hits using the inclusion criteria, the first author reduced the
number of studies to 25. Subsequently, both authors checked whether the 25
studies qualified for inclusion in the review. Seven of these 25 studies
reported on the follow-up of previously published data, reducing the number
of original studies to 18. An overview of the included studies is presented in
Table 1. If the results of a study have been published in more than 1 paper,
the papers are listed under the name of the first author of the first publication.
The identified studies were not suited for a meta-analysis, a more sys-
tematic review, or statistical weighting, given their heterogeneity in method-
ology, design, and the different time points used for assessing PTSD.
Nevertheless, to the extent that it was possible, we attempted to adhere to the




Eleven studies were identified that looked at the prevalence
of PTSD after MI. The prevalence rate in these studies varied
from 0% (26) to 22% (27). Some studies incorporated only
patients with a first MI, whereas other studies also included
patients with multiple MIs. When looking at prevalence rates
in patients with a first MI versus patients who had experienced
several MIs, some differences emerge. Prevalence rates in the
studies of first MI patients varied from 0% (26) to 22% (27),
whereas in patients with multiple MIs, the prevalence rates
varied from 8% (28) to 20% (22). One study presented data as
to the temporal onset of PTSD and found that only 8% of their
PTSD cases had delayed onset (29).
SCA
Four studies looking at the prevalence of PTSD in survi-
vors of SCA were identified. The prevalence rate varied from
19% (30) to 38% (31); 19% was found in a study that assessed
PTSD close to the index event (mean 9.6 months [range 3–18
months]) (30), whereas studies evaluating PTSD caseness
22 months found prevalence rates of 27% (32) and 38% (31).
Although 3 studies found prevalence rates of a considerable
magnitude, a case-control study looking at the risk of PTSD
within various patient groups (extensive burns, spinal disorders,
amputations, major chest trauma, heart failure, and cardiac arrest)
did not identify SCA as a risk factor for PTSD (33).
CHF
Only 1 study has examined the risk of developing PTSD in
CHF patients. CHF was associated with a 49% increase in the
risk of PTSD in a case-control study of various patients groups
(extensive burns, spinal disorders, amputations, major chest
trauma, CHF, and cardiac arrest) (33). However, the study was
conducted in a veteran population, which limits the ability to
generalize the results.
CS
Four studies were identified that looked at PTSD following
CS (ie, coronary artery bypass grafting, aortic valve replace-
ment, and cardiac valve replacement). One study focused on
children aged 5 to 12 scheduled for CS due to congenital heart
disease (34). The prevalence rates of these studies varied from
8% (28) to 18% (35), with the congenital heart disease pop-
ulation showing a prevalence of 12% (34). Two of the studies
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were cross-sectional with PTSD caseness being assessed
relatively soon after CS (range, 4.5–12 months), and 2 were
prospective, with PTSD caseness being assessed before and
relatively soon after CS (range, 1–6 months); no information
was available on the prevalence of PTSD beyond 12 months.
Heart Transplantation (HT)
We only found 1 study that looked at PTSD in relation to
HT, but this study was prospective and evaluated the preva-
lence of PTSD at several time points (36–40). The prevalence
rates varied from 10.8% (40) to 15.8% (37). The cumulative
prevalence rates at 7, 12, and 36 months post-HT were 9.6%,
15.6%, and 17%, respectively (39). It is noteworthy that after
12 months, only 1 new case of PTSD was identified, suggest-
ing that late onset is rare.
The Puzzle of Risk Factors
Kutz and colleagues (29) were the first to report on risk
factors for the development of PTSD in the aftermath of
MI. Subsequent studies have identified personality traits
(27,41,42), sociodemographic factors (eg, age, female sex,
and ethnic origin) (29,32,38,40,43), lack of social support
(39,40,43,44), previous psychiatric history (39), prior trauma-
tization (29), dissociative symptoms and acute stress disorder
at the time of MI (42,44,45), and aspects related to the cardiac
event (eg, the subjective perception of life threat and severity
of MI, awareness of having a cardiac event, and anticipated
incapacitation after MI) (22,29,45,43) as potential risk factors
for the development of PTSD in cardiac patients (Figure 1).
DISCUSSION
The methodology of the presented studies varies consider-
ably, making comparisons across studies difficult. Hence, the
difference in the prevalence rates of PTSD, together with risk
factors identified in the current review, is likely to be attrib-
uted to this heterogeneity. Nevertheless, the available studies
suggest that it is relevant to study PTSD in relation to CAD,
in particular given preliminary evidence that PTSD may lead
to nonadherence with medication and adverse clinical out-
come (22,46).
The most conclusive evidence comes from the study of MI
patients. Of note, PTSD has also been most rigorously re-
searched in MI patients. In general, the best-powered studies
found a prevalence rate ranging from 10% (46) to 16%
(42,45,47) 6 to 7 months after the index event and a preva-
lence of 24% and 14% in patients with a first MI at 4 to 6
weeks and 9 months, respectively (27,48). As late onset is rare
(29), taken together these studies suggest a prevalence rate of
around 15% in MI patients, allowing for a period of remission.
Results from studies of other cardiac conditions must be
considered inconclusive, given the paucity of studies avail-
able. Similarly, our knowledge of risk factors for the devel-
opment of PTSD in cardiac patients is sparse. Although
several risk factors have been identified, these factors have
been investigated in an unsystematic fashion.
In order to advance our knowledge of PTSD in relation to
CAD, future studies need to be conducted in a more system-
atic and methodologically sound fashion. Particular method-
ological issues influencing the prevalence rate pertain to the
time of assessment of PTSD, the choice of instrument (eg,
diagnostic interview versus self-report), the nature of the
cardiac event, which parameters (eg, demographic, social,
clinical, or aspects related to the event) are assessed, and the
power of the study.
Hence, future studies should be prospective and include
multiple assessments of PTSD. This would provide us with
more information about the natural course of PTSD in cardiac
patients and which patients may be at risk of chronic PTSD.
This is particularly important, given that PTSD symptoms
may remit spontaneously, as demonstrated in a recent pro-
spective study of first MI patients (48). Moreover, a study of
patients undergoing percutaneous coronary intervention found
that depression at 1 month was a better predictor of depressive
symptoms at 6 months compared with depression assessed at
the time of the index event (49).
Second, studies need to be sufficiently powered. With a
small sample size, the risk of obtaining a selected group of
patients is higher, in turn leading to a deflated or an inflated
prevalence rate. In the studies identified in this review, the
sample size varied from 23 (26) to 191 patients (38,39), with
Figure 1. Risk factors for PTSD in cardiac patients
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the study based on 23 patients identifying no cases of PTSD.
In order to increase power, patients with different cardiac
diagnoses have been pooled, but this may obscure the fact that
the type of cardiac event may influence the prevalence of
PTSD. O’Reilly and colleagues (30) compared the prevalence
rate between 2 diagnostic groups (27 SCA and 27 MI patients)
and found the prevalence to differ by 12%. Although this
difference was not statistically significant, this may be due to
reduced power. Therefore, pooling of small groups of patients
with different cardiac diagnoses is questionable unless a post
hoc power analysis is performed. To date, there is no conclu-
sive evidence that the prevalence rate in cardiac populations is
the same regardless of diagnostic group. In fact, it would seem
plausible that an acute event, such as MI, may lead to a higher
prevalence rate than, eg, valve replacement.
Third, the choice of instrument should be weighed care-
fully as this may also influence the prevalence rate. O’Reilly
and colleagues (30) compared the Posttraumatic Diagnostic
Scale (50) with the structured clinical interview and found a
correspondence of 0.39, as measured by Cohen’s . Foa and
colleagues (50) found a better correspondence (  0.65), but
their study was not conducted in cardiac patients. By nature,
cardiac events are different from other kinds of trauma, with
cardiac events being oriented toward the future, contrary to
general traumatic events that are oriented toward the past.
Hence, it has been suggested that measures used for diagnos-
ing PTSD in general trauma populations may not be ap-
propriate in cardiac populations (23). Although self-report
measures are often favored in empirical research as they are
less time consuming, future research should consider the im-
plications of choosing a self-report measure over a diagnostic
interview—the gold standard—and whether this self-report
measure has been validated in cardiac patients.
Fourth, it is important to note that the prevalence rate of
PTSD in cardiac patients cannot be considered in isolation but
needs to be weighed against the prevalence rate in the general
population. Given that it is costly to conduct epidemiological
studies, this information may not always be available. Epide-
miological studies have mainly been carried out in the United
States, finding a prevalence rate of 7.8% (51). Although
informative, this prevalence rate may not generalizable to
European populations. An alternative is to compare the prev-
alence rate in cardiac patients with that of a healthy matched
control group. In a study by Pedersen and colleagues (27), first
MI patients were above a 3-fold increased risk of developing
PTSD compared with healthy controls. This confirms that
cardiac patients are at increased risk of PTSD compared with
the general population.
Fifth, when studying risk factors for the development of
PTSD, current evidence suggests that several factors, includ-
ing sociodemographic factors (29,32,38,40), social support
(39,40,43,44), prior traumatization (29), previous psychiatric
history (39), aspects related to the cardiac event (26,29,45,41),
and personality may lead to the development of PTSD. Per-
sonality may be a particularly important explanatory factor of
individual differences in risk, as the distressed (Type D)
personality has been associated with a 4-fold increased risk of
PTSD in first MI patients and controls (41). Type D is defined
as the tendency to experience increased negative emotions
paired with the nonexpression of these emotions in social
interactions. Type D is an emerging prognostic risk factor in
CAD that has been associated with adverse prognosis inde-
pendent of established biomedical risk factors (52,53). We
would suggest that future studies attempt to include the ma-
jority of these potential risk factors using the same definitions,
as this would lead to a systematic investigation of the role of
these factors in the development of PTSD. Although poten-
tially informative, the use of ad hoc measures that appear
similar but may not be, eg, awareness of having an MI (54)
and subjective perception of life threat (42), restricts compar-
ison across studies. Furthermore, it will also be informative to
investigate whether risk factors have an additive or a syner-
gistic effect (21).
Sixth, future studies should take into account clinical risk
factors, including disease severity and previous (multiple)
cardiac events, as they may serve as confounders for PTSD.
Although perceived severity rather than severity of the MI as
determined by objective clinical criteria has been found to be
predictive of subsequent PTSD (45), this needs to be repli-
cated in other studies.
Finally, focusing on PTSD symptomatology may be of
equal importance to focusing on caseness, given that partial
PTSD also result in significant distress. For example, Dew and
colleagues (36) found that 73% of HT patients not diagnosed
with PTSD reported multiple PTSD-like symptoms, such as
intrusive thoughts. In turn, distress has been associated with
adverse health status and prognosis in cardiac patients
(2,52,55).
Consequences and Potential Mechanisms
There is increasing evidence that PTSD may have detri-
mental consequences for the health of cardiac patients. PTSD
has been shown to lead to impairments in social functioning,
vitality, physical health, and health status (45), increased
psychological distress (56), and adverse prognosis (22,37,46).
This suggests that PTSD may be a risk factor on par with
depression, and given their comorbidity, this would seem
plausible. The impact of depression on prognosis has been
researched extensively in cardiac patients, and depression has
been shown to be a sequel of CAD but also to confer an
increased risk of mortality and nonfatal MI (2,18,19,47). De-
pression has gained status as a risk factor alongside biomed-
ical risk factors (57), and hence it is not surprising that the
search for mechanisms explaining the link between depression
and cardiovascular prognosis is much further than that for
PTSD and CAD.
To our knowledge, only 2 studies in patients with estab-
lished CAD have investigated which mechanisms may ex-
plain the link between PTSD and adverse cardiac prognosis.
Shemesh and colleagues (22,46) found that PTSD was asso-
ciated with nonadherence with medication, in turn rendering
patients at risk of adverse clinical events. Ingestion of medi-
PTSD IN THE WAKE OF HEART DISEASE
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cation may serve as a reminder of the trauma, ie, the cardiac
event. Kario and colleagues (58) identified cardiovascular
reactivity to stress and hemostatic factors as other potential
pathways. Although they investigated changes in cardiovas-
cular risk factors in outpatients with hypertension after an
acute traumatic event rather than in patients with established
CAD, hypertension is a risk factor for incident CAD. A recent
review on cardiovascular effects of acute mental stress also
suggests that increases in heart rate, blood pressure and ar-
rhythmias, coagulation abnormalities, endothelial dysfunc-
tion, and platelet activation may comprise potential pathways
(59). Some of these pathways have also been confirmed in the
general PTSD literature (60,61) and are incorporated in the
“allostatic load model.” This model posits that PTSD presents
an imbalance in the allostatic systems that usually help the body
adapt to a variety of challenges (62). Chronic PTSD carries with
it psychobiological demands, such that the body must find new
steady states in which to maintain its vital functions. These new
states represent an accommodation to stress, but they also result
in sustained activity that places an excessive load on the allostatic
systems due to chronic over- or underactivity. In turn, this may
result in pathophysiological changes and eventually an increased
risk of medical illness (62).
Besides the consequences to the individual patient, PTSD
in relation to cardiac disease may also have consequences for
society in general in terms of increased health-care consump-
tion (7). However, recently it has been shown that although
PTSD alone and in combination with depression led to in-
creased use of health services, this use was not of an inappro-
priate nature (6).
CONCLUSIONS
Patients with CAD are at increased risk of PTSD, with a
prevalence rate of around 15% in MI patients. Despite a surge
in research investigating the link between PTSD and medical
illness in general, and heart disease in particular, there is an
urgent need for sufficiently powered and systematically con-
ducted prospective studies that look at the clinical course of
PTSD and its prognostic consequences for patients with es-
tablished CHD. A clarification of which risk factors lead to the
development of PTSD, which risk factors sustain this condi-
tion, and their relative impact would also provide us with a
better understanding of the pathogenic pathways of PTSD. In
turn, this would lead to better risk stratification in research and
clinical practice. Nevertheless, until such information is avail-
able, PTSD as a sequel of CAD should not be ignored in
clinical practice, given its impact on psychological distress,
health status, and preliminary evidence, suggesting that PTSD
leads to adverse prognosis and nonadherence with medication.
REFERENCES
1. Mackay J, Mensah G. Atlas of Heart Disease and Stroke. Geneva,
Switzerland, World Health Organization; 2004.
2. Blumenthal JA, Lett HS, Babyak MA. Depression as a risk factor for
mortality after coronary artery bypass surgery. Lancet 2003;362:604–9.
3. Pedersen SS, Lemos PA, van Vooren PR, Liu T, Daemen J, Erdman
RAM, Serruys PW, van Domburg RT. Type D personality predicts death
or myocardial infarction after bare metal stent or sirolimus-eluting stent
implantation: a Rapamycin-Eluting Stent Evaluated At Rotterdam Car-
diology Hospital (RESEARCH) registry sub-study. J Am Coll Cardiol
2004;44:997–1001.
4. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic
value of health status in patients with heart failure after acute myocardial
infarction. Circulation 2004;110:546–51.
5. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL,
Krumholz HM. Sex differences in health status after coronary artery
bypass surgery. Circulation 2003;108:2642–7.
6. Deykin EY, Keane TM, Kaloupek D, Fincke G, Rothendler J, Siegfried
M, Creamer K. Posttraumatic stress disorder and the use of health
services. Psychosom Med 2001;63:835–41.
7. Friedman MJ, Schnurr PP. The relationship between trauma, post-
traumatic stress disorder, and physical health. In: Friedman MJ, Charney
DS, eds. Neurobiological and Clinical Consequences of Stress: From
Normal Adaptation to Post-Traumatic Stress Disorder. Philadelphia: Lip-
pincott Williams & Wilkins Publishers; 1995:507–24.
8. Owen RL, Koutsakis S, Bennett PD. Post-traumatic stress disorder as a
sequel of acute myocardial infarction: An overlooked cause of psychos-
ocial disability. Coronary Health Care 2001;5:9–15.
9. Pedersen SS. Post-traumatic stress disorder in patients with coronary
artery disease: a review and evaluation of the risk. Scand J Psychol
2001;42:445–51.
10. Tedstone JE, Tarrier N. Posttraumatic stress disorder following medical
illness and treatment. Clin Psychol Rev 2003;23:409–48.
11. McFarlane A. Posttraumatic stress disorder: the intersection of epidemi-
ology and individual psychobiological adaptation. Curr Opin Psychiatry
2003;16:57–63.
12. Mezey G, Robbins I. Usefulness and validity of post-traumatic stress
disorder as a psychiatric category. BMJ 2001;323:561–3.
13. Summerfield D. The invention of post-traumatic stress disorder and the
social usefulness of a psychiatric category. BMJ 2001;322:95–8.
14. American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 3rd ed. Washington, DC: American Psychiatric
Association; 1980.
15. American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 3rd ed. Washington, DC: American Psychiatric
Association; 1987.
16. American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 4th ed. Washington, DC: American Psychiatric
Association; 1994.
17. Breslau N, Kessler RC. The stressor criterion in DSM-IV posttraumatic
stress disorder: an empirical investigation. Biol Psychiatry 2001;50:
699–704.
18. Van Melle JP, de Jonge P, Spijkerman TA, Tijssen JFP, Ormel J, van
Veldhuisen DJ, van den Brink RHS, van den Berg PM. Prognostic
association of depression following myocardial infarction with mortality
and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:
814–22.
19. Barth J, Schumacher M, Hermann-Lingen C. Depression as a risk factor
for mortality in patients with coronary heart disease: a meta-analysis.
Psychosom Med 2004;66:802–13.
20. Lyons D, McLoughlin DM. Recent advances: psychiatry. BMJ 2001;323:
1228–31.
21. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on
the pathogenesis of cardiovascular disease and implications for therapy.
Circulation 1999;99:2192–217.
22. Shemesh E, Yehuda R, Milo O. Posttraumatic stress, nonadherence, and
adverse outcome in survivors of a myocardial infarction. Psychosom Med
2004;66:521–6.
23. Mundy E, Baum A. Medical disorders as a cause of psychological trauma
and posttraumatic stress disorder. Curr Opin Psychiatry 2004;17:123–7.
24. Van der Wal MHL, Jaarsma T, van Veldhuisen, DJ. Non-compliance in
patients with heart failure: how can we manage it? Eur J Heart Fail
2005;7:5–17.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D,
Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observa-
tional studies in epidemiology: a proposal for reporting. JAMA 2000;
283:2008–12.
26. van Driel RC, Op den Velde W. Myocardial infarction and post-traumatic
stress disorder. J Trauma Stress 1995;8:151–9.
27. Pedersen SS, Middel B, Larsen ML. Posttraumatic stress disorder in
first-time myocardial infarction patients. Heart Lung 2003;32:300–7.
28. Doerfler LA, Pbert L, DeCosimo D. Symptoms of posttraumatic stress
H. SPINDLER AND S. S. PEDERSEN
722 Psychosomatic Medicine 67:715–723 (2005)
disorder following myocardial infarction and coronary artery bypass
surgery. Gen Hosp Psychiatry 1994;16:193–9.
29. Kutz I, Shabtai H, Solomon Z, Neumann M, David D. Post-traumatic
stress disorder in myocardial infarction patients: prevalence study. Isr
J Psychiatry Relat Sci 1994;31:48–56.
30. O’Reilly SM, Grubb N, O’Carroll RE. Long-term emotional conse-
quences of in-hospital cardiac arrest and myocardial infarction. Br J Clin
Psychol 2004;43:83–96.
31. Ladwig KH, Schoefinius A, Dammann G, Danner R, Gürtler R, Herr-
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